Literature DB >> 16867388

Determination of tamoxifen and five metabolites in plasma.

D Stevenson1, R J Briggs, D J Chapman, D De Vos.   

Abstract

Entities:  

Year:  1988        PMID: 16867388     DOI: 10.1016/0731-7085(88)80136-5

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


× No keyword cloud information.
  3 in total

1.  Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancer.

Authors:  D de Vos; P H Slee; D Stevenson; R J Briggs
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

3.  Evaluation of tamoxifen and metabolites by LC-MS/MS and HPLC methods.

Authors:  D D Heath; S W Flat; A H B Wu; M A Pruitt; C L Rock
Journal:  Br J Biomed Sci       Date:  2014       Impact factor: 3.829

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.